ATE526961T1 - Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff - Google Patents

Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff

Info

Publication number
ATE526961T1
ATE526961T1 AT08734289T AT08734289T ATE526961T1 AT E526961 T1 ATE526961 T1 AT E526961T1 AT 08734289 T AT08734289 T AT 08734289T AT 08734289 T AT08734289 T AT 08734289T AT E526961 T1 ATE526961 T1 AT E526961T1
Authority
AT
Austria
Prior art keywords
weight
mixture
atorvastatin
tablets
compressed
Prior art date
Application number
AT08734289T
Other languages
English (en)
Inventor
Alena Prokopova
Pavel Sebek
Michaela Dubovska
Vaclav Tomasek
Anna Hanovska
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of ATE526961T1 publication Critical patent/ATE526961T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AT08734289T 2007-03-02 2008-03-03 Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff ATE526961T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070169A CZ300047B6 (cs) 2007-03-02 2007-03-02 Farmaceutická kompozice s obsahem úcinné látky atorvastatinu
PCT/CZ2008/000024 WO2008106901A1 (en) 2007-03-02 2008-03-03 A pharmaceutical composition with atorvastatin active ingredient

Publications (1)

Publication Number Publication Date
ATE526961T1 true ATE526961T1 (de) 2011-10-15

Family

ID=39590531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08734289T ATE526961T1 (de) 2007-03-02 2008-03-03 Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff

Country Status (8)

Country Link
US (1) US20110038934A1 (de)
EP (1) EP2117534B1 (de)
AT (1) ATE526961T1 (de)
CZ (1) CZ300047B6 (de)
EA (1) EA015519B1 (de)
ES (1) ES2373492T3 (de)
UA (1) UA96321C2 (de)
WO (1) WO2008106901A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301299B6 (cs) * 2008-11-24 2010-01-06 Zentiva, A.S. Pevná farmaceutická kompozice s úcinnými látkami atorvastatinem a telmisartanem
HUP1000299A2 (hu) 2010-06-08 2012-02-28 Nanoform Cardiovascular Therapeutics Ltd Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
CN105168162A (zh) * 2015-09-06 2015-12-23 合肥华方医药科技有限公司 一种阿托伐他汀钙口腔速崩片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226636A1 (en) * 1998-03-18 1999-09-18 Keith Cornies Stacking pharmacapsule
GB0111077D0 (en) * 2001-05-04 2001-06-27 Biochemie Gmbh Organic compounds
ITMI20010538U1 (it) * 2001-10-03 2003-04-03 Pillot Massimo Contenitore portatile particolarmente studiato per confezioni tipo "blister",contenenti pastiglie di farmaci, prodotti dolciari, e altri pro
BR0307720A (pt) * 2002-02-14 2005-01-25 Ranbaxi Lab Ltd Formulações de atorvastatina estabilizadas com adições de metal alcalino, método para produzir uma formulação farmacêutica e estabilizar dita formulação
CA2519208A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Controlled release composition
CZ2003987A3 (cs) * 2003-04-08 2004-11-10 Zentiva A. S. Způsob výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbanioyl-2-(4- fluorfenyl)-5-isopropylpyrrol-l-yl]-3,5- dihydroxyheptanové kyseliny (atorvastatinu) vhodný pro průmyslovou výrobu a zařízení k jeho provádění
US7790197B2 (en) * 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
PT1653930E (pt) * 2003-08-05 2008-03-12 Zentiva As Métodos para a estabilização da atorvastatina
WO2005034908A2 (en) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S A solid dosage form comprising a fibrate and a statin
US20070014846A1 (en) * 2003-10-10 2007-01-18 Lifecycle Pharma A/S Pharmaceutical compositions comprising fenofibrate and atorvastatin
WO2006006021A2 (en) * 2004-06-28 2006-01-19 Glenmark Pharmaceuticals Limited Stabilized pharmaceutical compositions of preferably a statin
EP1808162A1 (de) * 2005-11-21 2007-07-18 Teva Pharmaceutical Industries Ltd. Pharmazeutische Formulierung von Atorvastatin
EP1810667A1 (de) * 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmazeutische Zusammensetzung enthaltend amorphes Atorvastatin
SI22255A (sl) * 2006-04-14 2007-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Novi polimorfi statinovih soli in njihova uporabav farmacevtskih formulacijah

Also Published As

Publication number Publication date
EP2117534A1 (de) 2009-11-18
ES2373492T3 (es) 2012-02-06
EA015519B1 (ru) 2011-08-30
CZ2007169A3 (cs) 2008-09-10
UA96321C2 (ru) 2011-10-25
US20110038934A1 (en) 2011-02-17
CZ300047B6 (cs) 2009-01-21
WO2008106901A8 (en) 2010-04-01
EA200901191A1 (ru) 2010-02-26
WO2008106901A1 (en) 2008-09-12
EP2117534B1 (de) 2011-10-05

Similar Documents

Publication Publication Date Title
HRP20200046T1 (hr) Formulacije apiksabana
Sekar et al. Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies
HRP20192026T1 (hr) Formulacija tableta od neratinib maleata
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
SI2821067T1 (en) Quick spray formulation of cinacalcet
HRP20161262T1 (hr) Tablete ulipristal acetata
CA2601955A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
WO2005009357A3 (en) Controlled release compositions
TW200427448A (en) Controlled release preparations comprising tramadol and topiramate
AR062509A1 (es) Proceso para preparar comprimidos de dihidrocloruro de pramipexol
CA2576652A1 (en) Granules comprising paracetamol, a nsaid and a sugar alcohol made by melt extrusion
RU2013125148A (ru) Пероральная фармацевтическая таблетка с регулируемым высвобождением месалазина и способ ее получения
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
EP1847260A3 (de) Feststoff-Dispersionspräparat
WO2008100240A3 (en) Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
ATE526961T1 (de) Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff
Saravanan et al. Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release kinetics
DE60212464D1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
CA2648667A1 (en) Sustained-release tablet production process
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
AR066000A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol
AR036797A1 (es) Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties